KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001366244-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
37,943
Total Value
$107,632.81
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 6, 2026 | Exercise/Conversion | 15,625 | โ | โ | 458,508 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 9, 2026 | Sale | 6,693 | $16.08 | $107,632.81 | 451,815 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Mar 6, 2026 | Exercise/Conversion | 15,625 | $0.00 | $0.00 | 125,001 | Direct | โ | View Details |